Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-03-29

Clinical Trial Update: Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea [NA]

View source ↗

Summary

A completed clinical trial evaluating the risk of postoperative nausea and vomiting with sevoflurane-remifentanil anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remifentanil (remifentanil)
  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Central Jutland Regional Hospital | Conditions: Nausea, Vomiting | NA | Status: COMPLETED